Hydrochloric Acid → (+/-)-3,4-Dihydro-1'-[2-(benzofurazan-5-yl)ethyl]-6-methanesulfonamido-spiro[(2H)-1-benzopyran-2,4'-piperidine]-4-ol hydrochloride
Reaction equation
[BH4-].[Na+].[N:3]1[O:7][N:6]=[C:5]2[CH:8]=[C:9]([CH2:12][CH2:13][N:14]3[CH2:19][CH2:18][C:17]4([CH2:24][C:23](=[O:25])[C:22]5[CH:26]=[C:27]([NH:30][S:31]([CH3:34])(=[O:33])=[O:32])[CH:28]=[CH:29][C:21]=5[O:20]4)[CH2:16][CH2:15]3)[CH:10]=[CH:11][C:4]=12.C(=O)([O-])O.[Na+].[ClH:40]>C(O)C.C(OCC)(=O)C>[ClH:40].[N:3]1[O:7][N:6]=[C:5]2[CH:8]=[C:9]([CH2:12][CH2:13][N:14]3[CH2:19][CH2:18][C:17]4([CH2:24][CH:23]([OH:25])[C:22]5[CH:26]=[C:27]([NH:30][S:31]([CH3:34])(=[O:32])=[O:33])[CH:28]=[CH:29][C:21]=5[O:20]4)[CH2:16][CH2:15]3)[CH:10]=[CH:11][C:4]=12Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
Sodium borohydride (7.5 mg, 0.2 mmol) was added to a stirred suspension of 3,4-dihydro-1'-[2-(benzofurazan-5-yl)ethyl]-6-methanesulfonamido-spiro[(2H)-1-benzopyran-2,4'-piperidine]-4-one [prepared as described in Example 94, Step B] (45.6 mg, 0.1 mmol) in ethanol (2 ml). The mixture was stirred for 16 hours, then poured into aqueous sodium hydrogen carbonate (saturated, 10 ml) and extracted with dichloromethane (3×10 ml). The combined organic fractions were dried (Na2SO4) and evaporated under reduced pressure to give a pale yellow oil. The residue was dissolved in ethyl acetate (2 ml) and ethanolic HCl (6N, 0.5 ml) was added. The mixture was cooled and the precipitate collected and dried in vacuo to give the hydrochloride as a white solid (32 mg, 65%), m.p.=242°-244° C.
Workup
- extractionextracted with dichloromethane (3×10 ml)
- dry with materialThe combined organic fractions were dried (Na2SO4)
- customevaporated under reduced pressure
- customto give a pale yellow oil
- temperatureThe mixture was cooled
- customthe precipitate collected
- customdried in vacuo
Sources & evidence
- ORD record
- ord-1deef3ab54144803bab9edf9dbee3418
- Source dataset
- uspto-grants-1997_05
- Patent number
- US05633247
Reaction notes
Loading…